Authors:
KOSOGLOU T
PATRICK JE
COHEN A
RADWANSKI E
CHRISTOPHER DC
AFFRIME MB
Citation: T. Kosoglou et al., PHARMACOKINETICS OF ISOSORBIDE-5-MONONITRATE AFTER ORAL-ADMINISTRATION OF AN EXTENDED-RELEASE MONONITRATE FORMULATION VERSUS A STANDARD DINITRATE FORMULATION, Clinical therapeutics, 17(2), 1995, pp. 241-251
Authors:
KOSOGLOU T
KAZIERAD DJ
SCHENTAG JJ
PATRICK JE
HEIMARK L
RADWANSKI E
CHRISTOPHER D
FLANNERY BE
AFFRIME MB
Citation: T. Kosoglou et al., EFFECT OF FOOD ON THE ORAL BIOAVAILABILITY OF ISOSORBIDE-5-MONONITRATE ADMINISTERED AS AN EXTENDED-RELEASE TABLET, Journal of clinical pharmacology, 35(2), 1995, pp. 151-158
Citation: C. Lin et al., MULTIPLE-DOSE PHARMACOKINETICS OF CEFTIBUTEN IN HEALTHY-VOLUNTEERS, Antimicrobial agents and chemotherapy, 39(2), 1995, pp. 356-358
Authors:
LIN C
LIM J
RADWANSKI E
MARCO A
AFFRIME M
Citation: C. Lin et al., PHARMACOKINETICS AND DOSE PROPORTIONALITY OF CEFTIBUTEN IN MEN, Antimicrobial agents and chemotherapy, 39(2), 1995, pp. 359-361
Authors:
LIN CC
RADWANSKI E
KORDUBA C
CAYEN M
AFFRIME M
Citation: Cc. Lin et al., PHARMACOKINETICS OF INTRAVENOUSLY ADMINISTERED ISEPAMICIN IN MEN, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2774-2778
Authors:
LIN C
KORDUBA C
AFFRIME M
RADWANSKI E
NOMEIR A
BATRA V
CUTLER D
CAYEN MN
Citation: C. Lin et al., PHARMACOKINETICS AND METABOLISM OF C-14 ISEPAMICIN IN HUMANS FOLLOWING INTRAVENOUS ADMINISTRATION, Antimicrobial agents and chemotherapy, 39(10), 1995, pp. 2201-2203
Authors:
SAANO V
GLUE P
BANFIELD CR
REIDENBERG P
COLUCCI RD
MEEHAN JW
HARING P
RADWANSKI E
NOMEIR A
LIN CC
JENSEN PK
AFFRIME MB
Citation: V. Saano et al., EFFECTS OF FELBAMATE ON THE PHARMACOKINETICS OF A LOW-DOSE COMBINATION ORAL-CONTRACEPTIVE, Clinical pharmacology and therapeutics, 58(5), 1995, pp. 523-531
Authors:
HULSMAN JARJ
RENTMEESTER TW
BANFIELD CR
REIDENBERG P
COLUCCI RD
MEEHAN JW
RADWANSKI E
MOJAVERIAN P
LIN CC
NEZAMIS J
AFFRIME MB
GLUE P
Citation: Jarj. Hulsman et al., EFFECTS OF FELBAMATE ON THE PHARMACOKINETICS OF THE MONOHYDROXY AND DIHYDROXY METABOLITES OF OXCARBAZEPINE, Clinical pharmacology and therapeutics, 58(4), 1995, pp. 383-389
Authors:
BRANNAN MD
REIDENBERG P
RADWANSKI E
SHNEYER L
LIN CC
CAYEN MN
AFFRIME MB
Citation: Md. Brannan et al., LORATADINE ADMINISTERED CONCOMITANTLY WITH ERYTHROMYCIN - PHARMACOKINETIC AND ELECTROCARDIOGRAPHIC EVALUATIONS, Clinical pharmacology and therapeutics, 58(3), 1995, pp. 269-278
Authors:
REIDENBERG P
GLUE P
BANFIELD CR
COLUCCI RD
MEEHAN JW
RADWANSKI E
MOJAVARIAN P
LIN CC
NEZAMIS J
GUILLAUME M
AFFRIME MB
Citation: P. Reidenberg et al., EFFECTS OF FELBAMATE ON THE PHARMACOKINETICS OF PHENOBARBITAL, Clinical pharmacology and therapeutics, 58(3), 1995, pp. 279-287
Authors:
HUHN RD
OCONNELL SM
RADWANSKI E
CUTLER DL
STURGILL M
CLARKE L
SEIBOLD JR
Citation: Rd. Huhn et al., PHASE-I PHARMACODYNAMIC STUDY OF INTRAVENOUS (IV) RECOMBINANT HUMAN INTERLEUKIN-10 (RHIL-10) IN NORMAL VOLUNTEERS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 162-162
Authors:
BRANNAN MD
AFFRIME MB
RADWANSKI E
CAYEN MN
BANFIELD C
Citation: Md. Brannan et al., EFFECTS OF VARIOUS CYTOCHROME-P450 INHIBITORS ON THE METABOLISM OF LORATADINE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 193-193
Authors:
MOJAVERIAN P
RADWANSKI E
AFFRIME MB
CAYEN MN
LIN CC
Citation: P. Mojaverian et al., PHARMACOKINETICS OF THE TRIAZOLE ANTIFUNGAL AGENT GENACONAZOLE IN HEALTHY-MEN AFTER ORAL AND INTRAVENOUS ADMINISTRATION, Antimicrobial agents and chemotherapy, 38(12), 1994, pp. 2758-2762
Authors:
SWAN SK
RADWANSKI E
CUTLER D
AFFRIME M
SCOTT M
HALSTENSON C
Citation: Sk. Swan et al., PHARMACOKINETICS OF FLUTAMIDE (F) IN PATIENTS WITH RENAL-INSUFFICIENCY (RI), Clinical pharmacology and therapeutics, 55(2), 1994, pp. 207-207